PDRX (PD-RX Pharmaceuticals) EV-to-EBIT: (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PD-RX Pharmaceuticals EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PD-RX Pharmaceuticals's Enterprise Value is $0.00 Mil. PD-RX Pharmaceuticals does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PD-RX Pharmaceuticals's EV-to-EBIT at this moment.

The historical rank and industry rank for PD-RX Pharmaceuticals's EV-to-EBIT or its related term are showing as below:

PDRX's EV-to-EBIT is not ranked *
in the Medical Distribution industry.
Industry Median: 11.17
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PD-RX Pharmaceuticals's Enterprise Value for the quarter that ended in . 20 was $0.00 Mil. PD-RX Pharmaceuticals does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PD-RX Pharmaceuticals's Earnings Yield (Joel Greenblatt) % at this moment.

PD-RX Pharmaceuticals  (OTCPK:PDRX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PD-RX Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %

PD-RX Pharmaceuticals EV-to-EBIT Related Terms

PD-RX Pharmaceuticals EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for PD-RX Pharmaceuticals's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PD-RX Pharmaceuticals EV-to-EBIT Chart

PD-RX Pharmaceuticals Annual Data
Trend
EV-to-EBIT

PD-RX Pharmaceuticals Quarterly Data
EV-to-EBIT

PDRX vs SNYR, FZMD: EV-to-EBIT Comparison

For the Medical Distribution subindustry, PD-RX Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PD-RX Pharmaceuticals EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PD-RX Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PD-RX Pharmaceuticals's EV-to-EBIT falls into.


PD-RX Pharmaceuticals EV-to-EBIT Calculation

PD-RX Pharmaceuticals's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/
=

PD-RX Pharmaceuticals Business Description

Address 727 North Ann Arbor Avenue, Oklahoma City, OK, USA, 73127-5822
PD-RX Pharmaceuticals Inc provides and distributes a complete line of brand and generic pharmaceuticals, unit dose products, unit of use, injectables, creams, ointments, and medical and surgical supplies.